Geoff’s Narration The GIST For me the risk is small and the (potential) benefit is huge. Dr. Kaufman We’re back, focusing on GLP-1-enhancing drugs. Why another GLP-1 blog? Because new information keeps pouring out. Plus, these surprise drugs constitute perhaps the most exciting treatment possibility ever seen in ME/CFS, […] The post The GLP-1 Agonist Boom in ME/CFS, FM and Long COVID: Insights, Using it, Trials Underway appeared first on Health Rising.| Health Rising
FRAXA funds Quiver Biosciences to validate a novel antisense oligonucleotide (ASO) therapy for Fragile X syndrome, targeting the root cause of the disorder. The post Validate a Novel Antisense Oligonucleotide Therapeutic for Fragile X Syndrome appeared first on FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome.| FRAXA Research Foundation – Finding a Cure for Fragile X Syndrome